Gwella focuses on constructing an accessible, authentic and scalable over-the-counter portfolio of useful and psychedelic mushroom merchandise that improve particular person and neighborhood wellness. The corporate’s superior direct-to-consumer platform combines an progressive mixture of wellness, mushrooms and psychedelics with a contemporary twist in an integration of media and expertise.
Gwella Wellness is the corporate’s purpose-built shopper product vertical. Utilizing unique components, formulations, supply methods, testing and analysis, Gwella Branded CPG tackles well being and wellness by means of excessive quantity avenues in retail, e-commerce and scientific, retreat and authorized jurisdictions. Its product pipeline contains Gwella’s flagship Mojo, Journey, and incoming MYMYCO, Yugen and Anxiousness Strips, with extra merchandise in growth.
Mojo, the corporate’s first psychedelic asset is the world’s first psilocybin-free Microdose product with a provisional patent filed and scientific trials underway. Mojo Microdose was hailed as Shopper Product of the 12 months in the course of the 1st Annual Microdose Awards. The psychedelic-based gummy edible makes use of proprietary parts, unique and premium components and is engineered over 12 months of R&D. Likewise, the flagship product accommodates proprietary IP, together with excessive Bioactive Cordyceps focus and 14 completely different bioactives.
Firm Highlights
- Gwella is constructing a number one model and trendy various wellness platform that exists on the intersection of three megatrends: useful well being, mushrooms and psychedelics.
- Gwella goals to curate an ecosystem of merchandise, content material and instruments that work collectively as a flywheel and central hub for the mainstream viewers inquisitive about psychedelics and wellness.
- Gwella’s flagship product, Mojo, is the world’s first psilocybin-free Microdose product with a provisional patent filed and scientific trials underway.
- Gwella Know-how entails the corporate’s first proprietary B2B and B2C device suite, CAPture app, which processes real-time knowledge consumption and market intelligence to forecast present developments in psychedelic shopper markets.
- The corporate’s content material platform covers an intersection of psychedelics and wellness by means of a media IP and emphasis on neighborhood creation.
- The following steps for Gwella embrace specializing in creating its expertise and media channels in addition to its sturdy R&D pipeline with six additional merchandise in growth.
- The corporate leverages advantageous positioning with its proprietary IP, together with excessive Bioactive Cordyceps focus
- The corporate is backed by a few of the high funds within the psychedelic and CPG area, together with Vine Ventures, Ambria, Vice Ventures, The Acutely aware Fund, Palo Santo and JLS Fund.
- The corporate has a top-tier administration group with over 50 years of CPG expertise and a confirmed observe report of success throughout a number of industries and massive model publicity.
Click on right here to attach with Gwella Mushrooms to obtain an Investor Presentation